Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

MOTOVSKA Zuzana HLINOMAZ Ota MROZEK Jan KALA Petr JARKOVSKÝ Jiří

Year of publication 2023
Type Article in Periodical
Magazine / Source European Journal of Internal Medicine
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.sciencedirect.com/science/article/pii/S095362052300184X?via%3Dihub
Doi http://dx.doi.org/10.1016/j.ejim.2023.05.032
Keywords cardiogenic shock; acute myocardial infarction; COVID-19
Description SARS-CoV-2 predisposes patients to thrombotic disease due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. The infection was recognized as an independent risk factor for acute myocardial infarction (AMI), which is considered part of the clinical picture of the COVID-19 disease. Cardiovascular disease increases both the susceptibility to SARS-COV-2 and the risk of death in patients with COVID-19. Among those who died and were COVID PCR-positive, almost one-third (30%) suffered from ischemic heart disease .
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.